The inhibitory effects of transforming growth factor β1 on breast cancer cell proliferation are mediated through regulation of aberrant nuclear factor-κB/Rel expression

Cell Growth and Differentiation

Volumn 10, Issue 8, 1999, Pages 537-544

  Sovak, Mika A ^a   Arsura, Marcello ^a   Zanieski, Gregory ^a   Kavanagh, Kathryn T ^a   Sonenshein, Gail E ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR REL; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL STRUCTURE; DRUG EFFECT; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; HALF LIFE TIME; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BINDING; PROTEIN STABILITY;

ANIMALS; BINDING, COMPETITIVE; BREAST NEOPLASMS; CELL DIVISION; CYTOPLASM; DNA-BINDING PROTEINS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; I-KAPPA B PROTEINS; IMMUNOBLOTTING; MICE; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-REL; SENSITIVITY AND SPECIFICITY; TRANSCRIPTION FACTOR RELA; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0032771824     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Massague, J. The transforming growth factor-β family. Annu. Rev. Cell Biol., 6: 597-641, 1990.
2. Rotello, R. J., Liberman, R. C., Purchio, A. F., and Gershenson, L. E. Coordinated regulation of apoptosis and cell proliferation by transforming growth factor β1 in cultured uterine epithelial cells. Proc. Natl. Acad. Sci. USA, 88: 3412-3415, 1991.
3. Havrilesky, L. J., Hurteau, J. A., Whitaker, R. S., Elbendary, A., Wu, S., Rodriguez, G. C., Bast, R. C., Jr., and Berchuck, A. Regulation of apoptosis in normal and malignant ovarian epithelial cells by transforming growth factor β. Cancer Res., 55: 944-948, 1995.
4. Valverius, E. M., Walker-Jones, D., Bates, S. E., Stampfer, M. R., Clark, R., McCormick, F., Dickson, R. B., and Lippman, M. E. Production of and responsiveness to TGF-β in normal and oncogene-transformed human mammary epithelial cells. Cancer Res., 49: 6269-6274, 1989.
5. Hosobuchi, M., and Stampfer, M. R. Effects of transforming growth factor β on growth of human mammary epithelial cells in culture. In Vitro Cell. Dev. Biol. Anim., 25: 705-713, 1989.
6. Pierce, D. F., Jr., Gorska, A. E., Chytil, A., Meise, K. S., Page, D. L., Coffey, R. J., Jr., and Moses, H. L. Mammary tumor suppression by transforming growth factor β 1 transgene expression. Proc. Natl. Acad. Sci. USA, 92: 4254-4258, 1995.
7. Silberstein, G. B., and Daniel, C. W. Reversible inhibition of mammary gland growth by transforming growth factor-β. Science (Washington DC), 236: 291-293, 1987.
8. Zugmaier, G., Ennis, B. W., Deschauer, B., Katz, D., Knabbe, C., Wilding, G., Daly, P., Lippman, M. E., and Dickson, R. B. Transforming growth factors type β1 and β2 are equipotent growth inhibitors of human breast cancer cell lines. J. Cell. Physiol., 141: 353-361, 1989.
9. Atwood, C. S., Ikeda, M., and Vonderhaar, B. K. Involution of mouse mammary glands in whole organ culture: a model for studying programmed cell death. Biochem. Biophys. Res. Comm., 207: 860-867, 1995.
10. Chen, H., Tritton, T. R., Kenny, N., Absher, M., and Chiu, J. F. Tamoxifen induces TGF-β1 activity and apoptosis of human MCF-7 breast cancer cells in vitro. J. Cell. Biochem., 61: 9-17, 1996.
11. Brattain, M. G., Ko, Y., Banerji, S. S., Wu, G., and Willson, J. K. V. Defects of TGF-β receptor signaling in mammary cell tumorigenesis. J. Mammary Gland Biol. Neoplasia, 1: 365-372, 1996.
12. 1/S growth arrest. Mol. Cell. Biol., 11: 1185-1194, 1991.
13. Ewen, M. E., Sluss, H. K., Whitehouse, L. L., and Livingston, D. M. TGFβ inhibition of Cdk4 synthesis is linked to cell cycle arrest. Cell, 74: 1009-1020, 1993.
14. Hannon, G. J., and Beach, D. p15 is a potential effector of TGFβ-induced cell cycle arrest. Nature (Lond.), 371: 257-262, 1994.
15. Laiho, M., DeCaprio, J. A., Ludlow, J. W., Livingston, D. M., and Massague, J. Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation. Cell, 62: 175-185, 1990.
16. Pietenpol, J. A., Stein, R. W., Moran, E., Yaciuk, P., Schlegel, R., Lyons, R. M., Pittelkow, M. R., Munger, K., Howley, P. M., and Moses, H. L. TGFβ1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell, 61: 777-785, 1990.
17. Coffey, R. J., Bascom, C. C., Sipes, N. J., Graves-Deal, R., Weissman, B. E., and Moses, H. L. Selective inhibition of growth-related gene expression in murine keratinocytes by transforming growth factor-β. Mol. Cell. Biol., 8: 3088-3093, 1988.
18. Arsura, M., Wu, M., and Sonenshein, G. E. TGF-β1 inhibits NF-κB/Rel activity inducing apoptosis of B cells: transcriptional activation of IκB-α. Immunity, 5: 31-40, 1996.
19. Arsura, M., FitzGerald, M. J., Fausto, N., and Sonenshein, G. E. NF-κB/Rel blocks transforming growth factor-β1 -induced apoptosis of murine hepatocyte cell lines. Cell Growth Differ., 8: 1049-1059, 1997.
20. Grilli, M., Chiu, J. J., and Lenardo, M. J. NF-κB and Rel: participants in a multiform transcriptional regulatory system. Int. Rev. Cytol., 143; 1-62, 1993.
21. Grimm, S., and Baeuerle, P. A. The inducible transcription factor NF-κB: Structure-function relationship of its protein subunits. Biochem. J., 290: 297-308, 1993.
22. Baeuerle, P. A., and Baltimore, D. IκB: a specific inhibitor of the NF-κB transcription factor. Science (Washington DC), 242: 540-546, 1988.
23. Haskill, S., Beg, A., Tompkins, S. M., Morris, J. S., Yurochko, A. D., Sampson-Johannes, A., Modal, K., Ralph, P., and Baldwin, A. S. Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity. Cell, 65: 1281-1289, 1991.
24. Thompson, J. E., Phillips, R. J., Erdjement-Bromage, H., Tempst, P., and Ghosh, S. IκBβ regulates the persistent response in biphasic activation of NF-κB. Cell, 80: 573-582, 1995.
25. Verma, I. M., Stevenson, J. K., Schwarz, E. M., Van Antwerp, D., and Miyamoto, S. Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev., 9: 2723-2735, 1995.
26. Sovak, M. A., Bellas, R. E., Kim, D. W., Zanieski, G. J., Rogers, A. E., Traish, A. M. and Sonenshein, G. E. Aberrant NF-κB/Rel expression and the pathogenesis of breast cancer. J. Clin. Invest., 100: 2952-2960, 1997.
27. Ko, Y., Banerji, S. S., Liu, Y., Li, W., Liang, J., Soule, H. D., Poauley, R. J., Willson, J. K., Zborowska, E., and Brattain, M. G. Expression of transforming growth factor-β receptor II and tumorigenicity in human breast adenocarcinoma MCF-7 cells. J. Cell. Physiol., 176: 424-434, 1998.
28. Yue, J., Buard, A., and Mulder, K. M. Blockade of TGFβ3 up-regulation of p27Kip1 and p21Cip1 by expression of RasN17 in epithelial cells. Oncogene, 17: 47-55, 1998.
29. Duyao, M. P., Buckler, A. J., and Sonenshein, G. E. Interaction of an NF-κB-like factor with a site upstream of the c-myc promoter. Proc. Natl. Acad. Sci. USA, 87: 4727-4731, 1990.
30. Lee, H., Arsura, M., Wu, M., Duyao, M., Buckler, A. J., and Sonenshein, G. E. Role of Rel-related factors in control of c-myc gene transcription in receptor-mediated apoptosis of the murine B cell WEHI231 line. J. Exp. Med., 181: 1169-1177, 1995.
31. Kessler, D. J., Duyao, M. P., Spicer, D. B., and Sonenshein, G. E. NF-κB-like factors mediate interieukin 1 induction of c-myc gene transcription in fibroblasts. J. Exp. Med., 176: 787-792, 1992.
32. Bellas, R. E., Lee, J. S., and Sonenshein, G. E. Expression of a constitutive NF-κB-like activity is essential for proliferation of cultured bovine vascular smooth muscle cells. J. Clin. Invest., 96: 2521-2527, 1995.
33. Tewari, M., Dobrzanski, P., Mohn, K. L., Cressman, D. E., Hsu, J. C., Bravo, R., and Taub, R. Rapid induction in regenerating liver of RL/IF-1 (an I-κ-B that inhibits NF-κB-relB-p50, and c-rel-p50) and PHF, a novel κB site-binding complex. Mol. Cell. Biol., 12: 2898-2908, 1992.
34. Fitzgerald, M. J., Webber, E. M., Donovan, J. R., and Fausto, N. Rapid DNA-binding by nuclear factor κB in hepatocytes at the start of liver-regeneration, Cell Growth Differ., 6: 417-427, 1995.
35. Iimuro, Y., Nshiura, T., Helerbrand, C., Berns, K. E., Schooen, R., Grisham, J. W., and Brenner, D. A. NF-κB prevents apoptosis and liver dysfunction during liver regeneration. J. Clin. Invest., 101: 802-811, 1998.
36. Perry, R. R., Kang, Y., and Greaves, B. R. Relationship between tamoxifen-induced transforming growth factor β1 expression, cytostasis and apoptosis in human breast cancer cells. Br. J. Cancer, 72: 1441-1445, 1995.
37. Barrett-Lee, P., Travers, M., Luqmani, Y., and Coombes, R. C. Transcripts for transforming growth factors in human breast cancer: clinical correlates. Br. J. Cancer, 61: 612-617, 1990.
38. Murray, P. A., Barrett-Lee, P., Travers, M., Luqmani, Y., Powles, T., and Coombes, R. C. The prognostic significance of transforming growth factors in human breast cancer. Br. J. Cancer, 67: 1408-1412, 1993.
39. Walker, R. A., and Dearing, S. J. Transforming growth factor β1 in ductal carcinoma in situ and invasive carcinomas of the breast. Eur. J. Cancer, 28: 641-644, 1992.
40. Gorsch, S. M., Memoli, V. A., Stukel, T. A., Gold, L. I., and Arrick, B. A. Immunohistochemical staining for transforming growth factor β1 associates with disease progression in human breast cancer. Cancer Res., 52: 6949-6952, 1992.
41. Auvinen, P., Lipponen, P., Hohansson, R., and Syrjanen, K. Prognostic significance of TGF-β1 and TGF-β2 expressions in female breast cancer. Anticancer Res., 15: 2627-2632, 1995.
42. Vincent, F., Hagiwara, K., Ke, Y., Stoner, G. D., Demetrick, D. J., and Bennett, W. P. Mutation analysis of the transforming growth factor β type III receptor in sporadic human cancers of the pancreas, liver, and breast. Biochem. Biophys. Res. Commun. 223: 561-564, 1996.
43. Kalkhoven, E., Roelen, B. A., de Winter, J. P., Mummery, C. L., van den Eijnden-van Raijj, A. J., van der Saag, P. T., and van der Burg, B. Resistance to transforming growth factor β and activin due to reduced receptor expression in human breast tumor cell lines. Cell Growth Differ., 6: 1151-1161, 1995.
44. 1/S phase transition and cooperates with c-myc to mediate progression to S phase. Mol. Cell. Biol., 17: 2448-2457, 1997.
45. Dignam, J. D., Lebovitz, R. M., and Roeder, R. G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res., 11: 1475-1489, 1983.
46. La Rosa, F. A., Pierce, J. W., and Sonenshein, G. E. Differential regulation of the c-myc oncogene promoter by the NF-κB/Rel family of transcription factors. Mol. Cell. Biol., 14: 1039-1044, 1994.